Monday 30 May 2016

SNP Genotyping and Analysis Market to Touch US$9.48 bn by 2019, Asia Pacific to Log Fastest Growth

The falling prices of sequencing have fanned research and development in SNP genotyping and analysis. Moreover, an increasing demand for breeding livestock will prove conducive to the growth of the global SNP genotyping and analysis market, says TMR in a new market research report. According to the report, titled, ‘SNP Genotyping and Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,’ the market will exhibit strong growth over the next three years. The market, which approximated US$2.38 bn in 2012, is expected to grow in value to reach US$9.48 bn by 2019. 


The introduction of new SNP genotyping technologies will have a far-reaching impact on the overall growth of the market, says TMR’s report. The positive impact of this trend will be visible in the robust growth projected to be exhibited by the market. The market is on course to exhibiting a compounded annual growth rate (CAGR) of 21.8% from 2013 to 2019. The heightened research interest in pharmacogenomics and livestock breeding has created opportunities of high economic value for companies in the SNP genotyping and analysis market.

Many of these opportunities will also make it possible for the average consumer in both developed and developing economies to access genotyping. However, the dynamics of the market are affected by the fact that there are nearly eight to 10 different kinds of SNP genotyping techniques, including Microarray, aqMan, MALDI-TOF, and SNPlex. What also aids the market’s growth is that over two million SNP genotypes have been added to a global database as part of the Human Genome Project. That has spurred numerous R&D activities in the genotyping and analysis market. Companies have invested bullishly in understanding how new diagnostic techniques similar to companion diagnostics can be developed so as to understand genome behavior as individuals age.

Food crops such as corn, oats, rice, wheat, and maize are undergoing intensive research after SNP genotyping in the agriculture sector having gained widespread acceptance. Several widely accepted products have been launched on the market as a result of this. A case in point is Affymetrix’s 44K array that is now extensively used for rice genotyping and helps farmers identify factors impacting yield.

The report segments the global genotyping market based on the following criteria: Technology, application, and geography. By technology, the market is segmented into Taqman Allelic Discrimination, SNP by Pyrosequencing, AB SNPlex, SNP GeneChips and Microarrays, MassARRAY MALDI-TOF. Likewise, by application type, the market is divided into the following segments: Breeding and animal livestock, pharmaceuticals and pharmacogenomics, agricultural biotechnology, and diagnostic research.

Furthermore, on the basis of geography, the market has been segmented into: Europe, North America, Asia Pacific, and Rest of the World. Regionally, North America represents the largest market for SNP technologies. A strong demand from the pharmacogenomics and livestock breeding sectors is likely to positively impact the global genotyping and analysis market. However, the highest growth is expected to come from the Asia Pacific region, which has been projected to report a CAGR of 23.1% through the report’s forecast period.

Leading companies profiled in this report include Illumina Inc., Roche, Life Technologies Corporation, Sequenom, Affymetrix Inc, and Fluidigm.

Full Research Report on Global SNP Genotyping and Analysis Market: 
http://www.transparencymarketresearch.com/snp-single-nucleotide-polymorphism-market.html

Wednesday 25 May 2016

Global Neonatal Warming Equipment Market 2013-2019

Neonatal care equipment are usually provided to preterm infants or newborn infants (upto 28 days) whose medical conditions are severe. Neonatal care equipment helps to supply oxygen, provide heat (in case of excessive heat loss) and help in monitoring vital parameters. Blood pressure monitors, cardiopulmonary monitors, bililights, endotracheal tube, incubators, nasal cannula, pulse oximeter, radiant warmer and ventilators are some of the neonatal care equipment.


Radiant warmer, also known as neonatal warming equipment help provide heat to infants suffering from severe heat loss. Infants have large body surface area as compared to their body volume along with very small volume of fat. Hence, infant’s body is not capable of maintaining proper body temperature that arouses the need for neonatal warming equipment. Neonatal warming equipment is an open bed, provided with a heat source to warm baby. Source of heat is infrared (IR) radiations that are beamed from quartz heater via parabolic reflector (circular paraboloid shaped reflective surface utilized to project energy). 

Thermistor temperature sensors are also incorporated in the equipment to detect the temperature of the equipment and hence help to provide appropriate warming to the neonate. Also, the equipment is designed with audible alarms and large display for temperature set. Height of neonatal warming equipment can be adjusted according to the bed height and also can be swivel to accommodate X-ray units. Neonatal warming equipment are portable in nature and can be transferred from labour room to neonatal intensive care units (NICU).

The market for neonatal warming equipment is expected to witness double digit growth rate compounded annually during the forecasted period. Rising incidences of preterm delivery is driving the growth of neonatal warming equipment market. It has been estimated by the World Health Organization (WHO) that around 15 million preterm births occur every year worldwide. Also, increasing prevalence rate of hospital acquired infections across the globe will propel the growth of neonatal warming equipment market since infants are susceptible to infections. In 2011, the New York State Department of Health reported that the incidence rate of hospital-onset Clostridium difficile infection (CDI) was 0.93 per 100 hospital admission patients in New York in 2011; it was 0.89 in 2010.

Launch of technologically advanced neonatal warming equipment in market will further augment the growth of the market. In addition, entrance of large number of companies into the manufacturing of neonatal warming equipment will also boost the growth of neonatal warming equipment market. Moreover, improving government initiatives will also support the growth of neonatal warming equipment market. For instance, the American Academy of Pediatrics (AAP) has added a level (level IV) in neonatal nursing that will draw the utilization of neonatal warming equipment extensively. Likewise, increasing number of hospitals worldwide will also elevate the growth of neonatal warming equipment market since according to government regulation; every hospital must have at least one neonatal intensive care unit (NICU) comprising of all neonatal care equipment. 

North America accounts for the largest share of total neonatal warming equipment market. This large market size is attributed to the high disposable income of the population in this region. Also, major manufacturers of neonatal warming equipment are domiciled in North America that also helped the region to contribute the largest market share. Asia-Pacific is expected to foresee the highest growth rate during the forecast period owing to rising incidences of preterm births in this region. Also, increasing disposable income of the nations like India and China will propel the growth of the market in the region. The major players operating in this market include GE Healthcare, Philips Healthcare, Smiths Medical, Fisher & Paykel Healthcare Corp., Phoenix Medical Systems Pvt Ltd. and Ibis Medical among other significant players.

Full Research Report on Global Neonatal Warming Equipment Market: 
http://www.transparencymarketresearch.com/neonatal-warming-equipment.html

Tuesday 24 May 2016

Demand for Clinical Diagnostics Propels Global Laboratory Information Systems Market at 7.70% CAGR

Transparency Market Research has published a new report on the global laboratory information system market. As per the report, the global laboratory information system market is predicted to progress from US$1,381.4 bn in 2013 to US$2,158.0 bn by 2019. The report, titled ‘Laboratory Information System Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019’, states that the global laboratory information system market is expected to expand at a 7.70% CAGR between 2013 and 2019.

Get a Free Sample Report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1482
 
Laboratory information systems are complex information systems developed and designed for the management of data related to medical laboratories and industries. Data from analytical and clinical laboratories is also managed by using enhanced laboratory information systems. With laboratory information system, users can obtain, store, retrace, manage, record, and alter laboratory information. This information is used for diagnosis, management, prevention, and treatment of various diseases. Laboratory information systems are custom developed as per the needs of a laboratory.

The growing need to custom-design and develop laboratory systems as per the changing needs of laboratories is expected to propel the global laboratory information system market during the forecast period. The global laboratory information system market is expected to develop rapidly due to factors such as increasing investment by healthcare IT players, increasing initiatives taken by the governments of various countries, and improvements in healthcare services. However, factors such as the lack of knowledgeable professionals, the high cost of laboratory information systems, and high maintenance requirements are expected to restrict the growth of the global laboratory information system market in the years to come.

The global laboratory information system market is segmented on the basis of region, component, delivery mode, and application. Based on region, the global laboratory information system market is divided into North America, Asia, Europe, and Rest of the World. In terms of units, the North America laboratory information system market is predicted to dominate the global laboratory information system market in the years to come. McKesson Corporation, Sunquest Information Systems, CompuGroup Medical (Germany), Merge Healthcare, Orchard Software, TechniData America, Siemens Medical Solutions, HEX Laboratory Systems, Cerner Corporation Medical Information Technology (Meditech), SCC Soft Computer, EPIC Systems Corporation, and Computer Programs and Systems Inc. are some of the leading companies in the global laboratory information system market.

By component, the global laboratory information system market is classified into software, services, and hardware. Factors such as growing use of smartphones and the increasing number of companies focusing on launching new products are expected to create new opportunities for the global laboratory information system market in the years to come. Based on the delivery mode, the global laboratory information system market is classified into web-based, cloud-based, and on-premise.

Drug delivery laboratory information systems and clinical diagnostics laboratory information systems are two of the major application segments of the global laboratory information system market. The clinical diagnostics laboratory information systems segment is expected to expand at an 8.90% CAGR during the period from 2013 to 2019.

Full Research Report on Global Laboratory Information System Market: 
http://www.transparencymarketresearch.com/laboratory-information-systems.html

Monday 23 May 2016

Need to Reduce Healthcare Costs Drives Medical Equipment Rental Businesses


Transparency Market Research, a global market intelligence firm, has recently announced the publication of a new market research report made available on the company website. The research study, titled “Medical Equipment Rental Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020,” talks about the global medical equipment rental market, presenting an overview of the market, along with the drivers and barriers that will determine the growth of the market throughout the forecast period.

Get a Free Sample Report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2543
 
According to the research report, in 2013, the global market for medical equipment rental was valued at US$33.4 bn and is estimated to reach a value of US$49.1 bn by the end of 2020. The market is projected to register a 5.80% CAGR between 2014 and 2020.

The rising pressure to reduce expenses in hospitals, the growing incidence of chronic diseases, increasing geriatric population, and safety against obsolescence of technologies are some of the major factors that are expected to boost the demand for medical equipment rental throughout the forecast period. Moreover, the expansion of the distribution network in developing countries is further expected to fuel the growth of the market. However, the poor pricing flexibility and absence of appropriate regulatory policies are projected to hamper the growth of the global medical equipment rental market in the near future.

The global medical equipment rental market has been classified on the basis of device category into surgical equipment, electronic/digital equipment, personal/home care equipment, durable medical equipment, and storage and transport. In 2013, the durable medical equipment segment held a 40% share of the global medical equipment rental market. This segment is projected to remain in its leading position in the forecast period, exhibiting a 5% CAGR between 2014 and 2020.

Furthermore, the global medical equipment rental market has been categorized on the basis of end use into medical equipment rental, personal/home care, and institutional medical equipment rental. In 2013, the chronic and geriatric patient sub-category of personal/home care held a 50% share of the overall personal/home care segment.

On the basis of geography, the global medical equipment rental market has been divided into Asia Pacific, Europe, North America, and Rest of the World. In 2013, Europe led the global market, accounting for a 30% share in the overall medical equipment rental market, followed by the North America medical equipment rental market. The North America market is estimated to surpass Europe in the next few years. On the other hand, the Asia Pacific market for medical equipment rental is anticipated to register the highest growth rate – a 6% CAGR between 2014 and 2020.

Furthermore, the research study covers the competitive landscape of the global medical equipment rental market, including detailed profiles of the major players operating in the market. As per the study, the global medical equipment rental market is extremely fragmented, owing to the dominance of a few large players such as Siemens Financial Services, Apria Healthcare Group, Stryker Corporation, and Hill-Rom Holdings, Inc.

Some of the other players in the market are Universal Hospital Services, Inc., Port Huron Hospital Medical Equipment, Hill-Rom Holdings, Centric Health Corporation, Westside Medical Supply, Woodley Equipment Company Ltd., US Med-Equip, Nunn’s Home Medical Equipment, and Walgreen Co.

Full Research Report on Global Medical Equipment Rental Market: 
http://www.transparencymarketresearch.com/medical-equipment-rental.html

Thursday 19 May 2016

Gonorrhea Diagnostics Market - Global Industry Analysis and Forecast 2023

Gonorrhea is a sexually transmitted disease caused by the bacterium Neisseria gonorrhoeae and can affect both genders. It is a common infection, especially among young people aged between 15 years to 24 years. According to the U.S. Centers for Disease Control and Prevention (CDC), gonorrhea is the second most commonly reported disease in the United States affecting approximately 800,000 people each year. In the United Kingdom, about 28,000 cases of gonorrhea are reported each year. Symptoms of gonorrhea in men encompass painful urination, swelling of testicles and pus discharge. In women, symptoms comprise excessive vaginal discharge, painful urination and abdominal pain. Complications include ectopic pregnancy, Pelvic Inflammatory Disease (PID) and Epididymitis. The incubation period for this disease also varies between men and women. In men, the symptoms occur between 2 to 14 days whereas in women it takes 7 days to 21 days to show symptoms. Astonishingly, about 50% of women have no symptoms in the early stage and during pregnancy it may infect the fetus during delivery. 


Diagnostic tests for gonorrhea include diagnostic imaging, flow cytometry, gel microdroplets, chromatography, artificial intelligence, liposomes, differential light scattering (DLS), molecular diagnostics and monoclonal antibodies test. Amongst these tests, molecular diagnostics is the most commonly employed diagnostic test. Molecular diagnostic tests include Nucleic Acid Amplification Tests (NAAT) that are highly sensitive for urine and swab tests, and are U.S. FDA approved. Over the years, there has been a substantial increase in the number of patients suffering from gonorrhea. Changing lifestyle and involvement of multiple sex partners has substantially boosted the market for gonorrhea diagnostics. In last few years, both Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) have reported instances of antibiotic resistant strains in patients. This further exaggerates the demand for early diagnostic kits or tests on a global scale. However inadequate infrastructure, limited trained laboratory personnel and lack of awareness in developing countries are among the major restraints to the global gonorrhea diagnostics market. 

Geographically, the market is majorly driven by developed economic regions such as North America and Europe owing to presence of large number of point of care tests and high awareness among people with respect to sexually transmitted diseases. The U.S. Department of Health and Human Service recommend pelvic examination on an annual basis which also increases the growth prospects of this market. In 2013, the total number of new cases of gonorrhea diagnosed in genitourinary medicine (GUM) clinics in England was 29,291. This represented an increase of 15% compared to those diagnosed in 2012. However, in developing parts lack of appropriate knowledge and infrastructure has limited the growth prospects. Despite that, owing to increasing disposable incomes and changing lifestyles in developing regions, the market for gonorrhea is expected to have the fastest growth in Asia Pacific and Rest of the World regions. Recently in 2014, a new strain of gonorrhea known as A8806 was reported in Australia which is also multi-drug resistant. Such instances have raised concerns among researchers and government agencies owing to which, number of clinical trials in Asia Pacific region has drastically increased which will eventually boost the demand for diagnostic tests and kits.
  
Some of the key players operating the global gonorrhea diagnostics market include Siemens AG, Tosoh Corporation, PerkinElmer, Inc., Abbott Laboratories, Beckman Coulter Inc., Ortho Clinical Diagnostics, F. Hoffmann-La Roche AG, bioMérieux and others. 

Full Research Report on Global Gonorrhea Diagnostics Market: 
http://www.transparencymarketresearch.com/gonorrhea-diagnostic-market.html

Hemostasis and Tissue Sealing Agents Market to Reach US$5.2 bn in 2020, North America to Remain the Most Lucrative Market

Transparency Market Research has published a new report on the global hemostasis and tissue sealing agents market. As per the report, the global hemostasis and tissue sealing agents market stood at US$3.0 bn in 2013 and is expected to reach US$5.2 bn by 2020. The report, titled ‘Hemostasis and Tissue Sealing Agents Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020,’ states that the global market is expected to expand at an 8.0% CAGR from 2014 to 2020 owing to factors such as technological improvements and the growing aging population.


Hemostasis and tissue sealing agents play a vital role in simplifying wound sealing procedures during surgeries. Primarily, the global hemostasis and tissue sealing agents market is driven by the introduction of new products. For example, in May 2014, the Sylys Surgical Sealant was introduced by Cohera Medical, Inc.; it can be used in gastrointestinal surgery. In January 2014, Baxter received the U.S. FDA approval for the TISSEEL fibrin sealant that is used for various surgeries. The constant introduction of new products and the increasing adoption of technological innovations are expected to propel the global hemostasis and tissue sealing agents market in the years to come.

The increasing number of vascular, cardiovascular, pulmonary, and gastrointestinal surgeries has also increased the demand for hemostasis and tissue sealing agents. Factors such as the risk of complications of hemostasis and tissue sealing agents and strict regulatory requirements are expected to hamper the growth of the global hemostasis and tissue sealing agents market in the near future. However, the increasing investment in hemostasis and tissue sealing agents for developing agents is expected to benefit the global market in the near future.

Leading players are concentrating on introducing new innovative products in the global market. Some of the prominent companies operating in the global hemostasis and tissue sealing agents market are CryoLife, Inc., Advance Medical Solution Group plc, Pfizer, Inc., Johnson and Johnson, Baxter, and Integra LifeSciences Corporation.

The global hemostasis and tissue sealing agents market is segmented on the basis of product type and geography. Based on geography, the global market for hemostasis and tissue sealing agents is divided into North America, Asia Pacific, Europe, and Rest of the World. In 2013, North America dominated the global hemostasis and tissue sealing agents market owing to the rising number of pulmonary and cardiovascular surgeries. The Europe hemostasis and tissue sealing agents market is expected to expand at a 7.0% CAGR from 2014 to 2020 due to the introduction of products such as HEMOPATCH, TISEEL, and FLOSEAL.

Based on product type, the global hemostasis and tissue sealing agents market is segmented into topical hemostats and adhesive and tissue sealing agents. The adhesive and tissue sealing agents segment is predicted emerge as the dominant contributor in the global market throughout the forecast period. Improved research and development activities towards drug discovery are expected to propel the adhesive and tissue sealing segment.

Full Research Report on Global Hemostasis and Tissue Sealing Agents Market: 
http://www.transparencymarketresearch.com/hemostasis-tissue-sealing-agents-market.html